Claims
- 1. A method for treating cutaneous pain, said method comprising topically applying an effective amount of capsazepine to a patient in need of such treatment to prevent and/or combat cutaneous pain.
- 2. A method for treating cutaneous and/or ocular irritation, erythemas, pruritus or warming and/or dysaesthetic sensations of the skin, the eyes or mucous membranes, said method comprising topically applying an effective amount of capsazepine to a patient in need of such treatment to prevent and/or combat cutaneous and/or ocular irritation, erythema, pruritus or warming and/or dysaesthetic sensations of the skin or the eyes.
- 3. A method for treating symptoms related to shingles, eczema, sensitive skin or eyes, pruriginous diseases, pruritus, herpes, atopic or contact dermatitides, lichens, prurigos, insect stings, rosacea, conjunctivitis or uveitides, said method comprising topically applying an effective amount of capsazepine to a patient in need of such treatment to prevent and/or combat symptoms related to shingles, eczema, sensitive skin or eyes, pruriginous diseases, pruritus, herpes, atopic or contact dermatitides, lichens, prurigos, insect stings, rosacea, conjunctivitis or uveitides.
- 4. The method according to claim 1, wherein capsazepine is used in an amount ranging from 0.000001 to 5% by weight with respect to the total weight of the composition.
- 5. The method according to claim 2, wherein capsazepine is used in an amount ranging from 0.000001 to 5% by weight with respect to the total weight of the composition.
- 6. The method according to claim 3, wherein capsazepine is used in an amount ranging from 0.000001 to 5% by weight with respect to the total weight of the composition.
- 7. The method according to claim 4, wherein capsazepine is used in an amount ranging from 0.00001 to 0.5% by weight with respect to the total weight of the composition.
- 8. The method according to claim 5, wherein capsazepine is used in an amount ranging from 0.00001 to 0.5% by weight with respect to the total weight of the composition.
- 9. The method according to claim 6, wherein capsazepine is used in an amount ranging from 0.00001 to 0.5% by weight with respect to the total weight of the composition.
Priority Claims (1)
Number |
Date |
Country |
Kind |
95/13.096 |
Nov 1995 |
FR |
|
Parent Case Info
This application is a continuation of application Ser. No. 09/068,237, filed Jun. 18, 1998, now U.S. Pat. No. 6,048,85 which in turn is a 371 of PCT/FR96/01592, filed Oct. 11, 1996.
Non-Patent Literature Citations (1)
Entry |
BR.J. Pharmacol., vol. 107, No. 2, 1992, pp. 329-333, XP000576708, M.N. Perkins “Capsazepine reversal of the antinociceptive action of capsaicin in vivo”. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09/068237 |
|
US |
Child |
09/457667 |
|
US |